Loading provider…
- Featuresarrow_drop_down
- Solutionsarrow_drop_down
Loading provider…
Your Medical Sales Assistants that help you easily find, convert and close your ideal providersHematology & Oncology Physician in Chicago, IL
NPI: 1225337017Primary Practice Location
NORTHWESTERN MEMORIAL HOSPITAL
250 E Superior St, Chicago, IL
Primary Employer
Northwestern Medical Group
nm.org
HQ Phone
Get M.D. Karan's Phone Numberphone_androidMobile
Get M.D. Karan's MobileLooking to connect with more Physicians?
Dmand AI gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Get Started for Freearrow_outwardIL State Medical License
| # | Procedure Code (CPT®/HCPCS II) | Procedure Patients | Procedure Volume |
|---|---|---|---|
| 1 | 96413Infusion of chemotherapy into a vein up to 1 hour | 183 | 248 |
| 2 | 99215Established patient office or other outpatient, visit typically 40 minutes | 174 | 441 |
| 3 | 96375Injection of different drug or substance into a vein for therapy, diagnosis, or prevention | 139 | 274 |
| 4 | 96365Infusion into a vein for therapy, prevention, or diagnosis up to 1 hour | 109 | 140 |
| 5 | 96367Infusion into a vein for therapy prevention or diagnosis additional sequential infusion up to 1 hour | 73 | 128 |
Authors: Priya Kumthekar, Sean Sachdev, Rimas Lukas, Sean Grimm, Jeffrey Raizer, Steven Chmura, Minesh Mehta, Vinai Gondi
Journal: J Neurooncol
Publication Date: 2021-10-24
Recent advances in managing/understanding meningioma.
Authors: Jeffrey Raizer, Nawal Shaikh
Publication Date: 2018-04-17
Lead Sponsor: Northwestern University
Collaborators: Bristol-Myers Squibb, National Cancer Institute (NCI), CarThera
Intervention / Treatment: DEVICE: Sonication for opening of blood-brain barrier, DRUG: Chemotherapy, albumin-bound paclitaxel, DRUG: Chemotherapy, carboplatin
Lead Sponsor: National Cancer Institute (NCI)
Collaborators: NRG Oncology
Intervention / Treatment: OTHER: Questionnaire Administration, BIOLOGICAL: Nivolumab, DRUG: Temozolomide, BIOLOGICAL: Ipilimumab, OTHER: Quality-of-Life Assessment, RADIATION: Radiation Therapy, PROCEDURE: Contrast-enhanced Magnetic Resonance Imaging, DEVICE: NovoTTF-100A Device
Lead Sponsor: Northwestern University
Collaborators: National Cancer Institute (NCI)
Intervention / Treatment: OTHER: Laboratory Biomarker Analysis, OTHER: Pharmacological Study, DRUG: Targeted Molecular Therapy
